Lykos Therapeutics Announces Reorganization to Address FDA's Recent Decision on Midomafetamine Capsules for PTSD
Sens. Cory Booker (D-NJ) and Rand Paul (R-KY) likely don’t share much in common when it comes to policy views, but that didn’t stop the pair from introducing a new bill this week that would alter the controversial Right to Try Act to allow terminally ill patients to access Schedule I drugs after a Phase I trial has been completed.